Long-term outcomes with intensive induction chemotherapy (carboplatin, bleomycin, vincristine and cisplatin/bleomycin, etoposide and cisplatin) and standard bleomycin, etoposide and cisplatin in poor prognosis germ cell tumours: A randomised phase II trial (ISRCTN53643604). (2020)

First Author: Cafferty FH
Attributed to:  CANCER: Trials with potential global reach and other challenging trials funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.ejca.2019.12.028

PubMed Identifier: 32007714

Publication URI: http://europepmc.org/abstract/MED/32007714

Type: Journal Article/Review

Volume: 127

Parent Publication: European journal of cancer (Oxford, England : 1990)

ISSN: 0959-8049